These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 32979629)
21. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population. Malakhova AA; Grigor'eva EV; Pavlova SV; Malankhanova TB; Valetdinova KR; Vyatkin YV; Khabarova EA; Rzaev JA; Zakian SM; Medvedev SP Stem Cell Res; 2020 Oct; 48():101952. PubMed ID: 32805537 [TBL] [Abstract][Full Text] [Related]
22. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations. Moon HJ; Lee N; Moon JY; Lee JH; Kim JH Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467 [TBL] [Abstract][Full Text] [Related]
23. Generation of three human iPSC lines from patients with a spontaneous late-onset Alzheimer's disease and three sex- and age-matched healthy controls. Raska J; Klimova H; Sheardova K; Fedorova V; Hribkova H; Pospisilova V; Vochyanova S; Vanova T; Bohaciakova D Stem Cell Res; 2021 May; 53():102378. PubMed ID: 34088007 [TBL] [Abstract][Full Text] [Related]
24. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease. Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594 [TBL] [Abstract][Full Text] [Related]
26. Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions. Hamada A; Akagi E; Yamasaki S; Nakatao H; Obayashi F; Ohtaka M; Nishimura K; Nakanishi M; Toratani S; Okamoto T In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):85-95. PubMed ID: 31768763 [TBL] [Abstract][Full Text] [Related]
27. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual. Shang S; Chen K; Cai G; Bai X; Chen X; Li Q Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710 [TBL] [Abstract][Full Text] [Related]
28. Generation of induced pluripotent stem cell line (FMCPGHi001-A) from a 25-year-old Chinese Han healthy male donor. Wang T; Tang W; Zeng Q; Miao S; Pi C; Li Y; Yue W; Yu S Stem Cell Res; 2022 Apr; 60():102735. PubMed ID: 35247846 [TBL] [Abstract][Full Text] [Related]
29. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol. Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158 [TBL] [Abstract][Full Text] [Related]
30. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma. Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001 [TBL] [Abstract][Full Text] [Related]
31. Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression. Bono F; Mutti V; Piovani G; Minelli A; Mingardi J; Guglielmi A; Fiorentini C; Barbon A; Missale C; Gennarelli M Stem Cell Res; 2020 Dec; 49():102104. PubMed ID: 33291010 [TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation. Zapata-Linares N; Rodriguez S; Salido E; Abizanda G; Iglesias E; Prosper F; Gonzalez-Aseguinolaza G; Rodriguez-Madoz JR Stem Cell Res; 2016 Jan; 16(1):116-9. PubMed ID: 27345794 [TBL] [Abstract][Full Text] [Related]
33. Patient-derived stem cell line UKMi005-A (hiPSC) harboring a non-synonymous heterozygous KCNJ5 gene variant. Kayser A; Dittmann S; van Impel A; Šarić T; Schulze-Bahr E Stem Cell Res; 2023 Dec; 73():103223. PubMed ID: 37890333 [TBL] [Abstract][Full Text] [Related]
34. Successful Generation of Human Induced Pluripotent Stem Cell Lines from Blood Samples Held at Room Temperature for up to 48 hr. Agu CA; Soares FA; Alderton A; Patel M; Ansari R; Patel S; Forrest S; Yang F; Lineham J; Vallier L; Kirton CM Stem Cell Reports; 2015 Oct; 5(4):660-71. PubMed ID: 26388286 [TBL] [Abstract][Full Text] [Related]
35. Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patient. Lotila J; Hyvärinen T; Skottman H; Airas L; Narkilahti S; Hagman S Stem Cell Res; 2022 Aug; 63():102865. PubMed ID: 35843021 [TBL] [Abstract][Full Text] [Related]
36. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease. Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593 [TBL] [Abstract][Full Text] [Related]
37. Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male. Wu H; Cheng Y; Lv Z; Liu L; Gong W; Zhang S Stem Cell Res; 2021 May; 53():102221. PubMed ID: 33677395 [TBL] [Abstract][Full Text] [Related]
38. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient. Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004 [TBL] [Abstract][Full Text] [Related]
39. Generation of multiple human iPSC lines from peripheral blood mononuclear cells of two SLC2A3 deletion and two SLC2A3 duplication carriers. Ziegler GC; Radtke F; Vitale MR; Preuße A; Klopocki E; Herms S; Lesch KP Stem Cell Res; 2021 Oct; 56():102526. PubMed ID: 34492570 [TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor. Bono F; Mutti V; Piovani G; Minelli A; Mingardi J; Guglielmi A; Missale C; Gennarelli M; Fiorentini C; Barbon A Stem Cell Res; 2021 Mar; 51():102216. PubMed ID: 33548809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]